Literature DB >> 18158920

Canonical Wnt signaling maintains the quiescent stage of hepatic stellate cells.

Claus Kordes1, Iris Sawitza, Dieter Häussinger.   

Abstract

It is well known that hepatic stellate cells (HSC) develop into cells, which are thought to contribute to liver fibrogenesis. Recent data suggest that HSC are progenitor cells with the capacity to differentiate into cells of endothelial and hepatocyte lineages. The present study shows that beta-catenin-dependent canonical Wnt signaling is active in freshly isolated HSC of rats. Mimicking of the canonical Wnt pathway in cultured HSC by TWS119, an inhibitor of the glycogen synthase kinase 3beta, led to reduced beta-catenin phosphorylation, induced nuclear translocation of beta-catenin, elevated glutamine synthetase production, impeded synthesis of alpha-smooth muscle actin and Wnt5a, but promoted the expression of glial fibrillary acidic protein, Wnt10b, and paired-like homeodomain transcription factor 2c. In addition, canonical Wnt signaling lowered DNA synthesis and hindered HSC from entering the cell cycle. The findings demonstrate that beta-catenin-dependent Wnt signaling maintains the quiescent state of HSC and, similar to stem and progenitor cells, influences their developmental fate.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18158920     DOI: 10.1016/j.bbrc.2007.12.085

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  48 in total

Review 1.  Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad.

Authors:  Kari Nichole Nejak-Bowen; Satdarshan P S Monga
Journal:  Semin Cancer Biol       Date:  2010-12-21       Impact factor: 15.707

2.  R-spondin2 activates hepatic stellate cells and promotes liver fibrosis.

Authors:  Xinguang Yin; Huixing Yi; Wanxin Wu; Jing Shu; Xiaojun Wu; Linghua Yu
Journal:  Dig Dis Sci       Date:  2014-05-23       Impact factor: 3.199

3.  Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.

Authors:  Daniel Sepulveda-Crespo; Salvador Resino; Isidoro Martinez
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

4.  Elimination of Wnt Secretion From Stellate Cells Is Dispensable for Zonation and Development of Liver Fibrosis Following Hepatobiliary Injury.

Authors:  Rong Zhang; Alexander T Kikuchi; Toshimasa Nakao; Jacquelyn O Russell; Morgan E Preziosi; Minakshi Poddar; Sucha Singh; Aaron W Bell; Steven G England; Satdarshan P Monga
Journal:  Gene Expr       Date:  2018-09-20

Review 5.  Hepatic stem cell niches.

Authors:  Claus Kordes; Dieter Häussinger
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

Review 6.  Hepatic stellate cells in liver development, regeneration, and cancer.

Authors:  Chunyue Yin; Kimberley J Evason; Kinji Asahina; Didier Y R Stainier
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

7.  Targeting Endothelial Erk1/2-Akt Axis as a Regeneration Strategy to Bypass Fibrosis during Chronic Liver Injury in Mice.

Authors:  Yuanxiang Lao; Yanyan Li; Ping Zhang; Qianqian Shao; Weiran Lin; Bintao Qiu; Yongzhuang Lv; Lichun Tang; Shishuai Su; Hongyu Zhang; Chunyan Tian; Aihua Sun; Handong Wei; Pumin Zhang; Yan Wu; Ying Jiang; Fuchu He
Journal:  Mol Ther       Date:  2018-08-24       Impact factor: 11.454

8.  Curcumin eliminates oxidized LDL roles in activating hepatic stellate cells by suppressing gene expression of lectin-like oxidized LDL receptor-1.

Authors:  Qiaohua Kang; Anping Chen
Journal:  Lab Invest       Date:  2009-09-07       Impact factor: 5.662

9.  Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy.

Authors:  Angela Douglass; Karen Wallace; Matthew Koruth; Caroline Barelle; Andrew J Porter; Matthew C Wright
Journal:  Hepatol Int       Date:  2008-09-03       Impact factor: 6.047

10.  Hepatic stellate cells are involved in the pathogenesis of acute-on-chronic liver failure (ACLF).

Authors:  Archana Rastogi; Chhagan Bihari; Rakhi Maiwall; Arvind Ahuja; Manoj Kumar Sharma; Ashish Kumar; Shiv Kumar Sarin
Journal:  Virchows Arch       Date:  2012-08-11       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.